Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
E Kevin Hrusovsky, insider at Quanterix

E Kevin Hrusovsky Insider Information

CEO of Quanterix

Kevin Hrusovsky is the chairman, president and CEO of Quanterix, a precision health biotechnology company.

Hrusovsky joined the company in 2014 as executive chairman of the board. In 2015, he became president and CEO, working to digitize biomarker analysis to advance the science behind precision health. In 2017, he took Quanterix public in what became one of the most successful IPOs for a life sciences company in recent history. Under his tenure, the company also acquired Aushon and regained the rights to its Simoa technology. 

In addition to his role at Quanterix, Hrusovsky also serves as the founder and chairman of Powering Precision Health, the annual summit that has become the industry’s leading platform for advancing the deep science behind precision health. 

Prior to his work with Quanterix and Powering Precision Health, Hrusovsky served as the president of life sciences and technology for PerkinElmer from 2011 to 2013. Previously, for more than eight years, he was the president and CEO of Caliper Life Sciences, now part of PerkinElmer. He also worked with Zymark Limited as the company’s president and CEO from 1996 to 2003, with FMC for four years as president of pharmaceuticals and head of international agricultural products, and he held various high-level management positions for Dupont starting in 1983. 

Hrusovsky has earned numerous awards and accolades for his leadership and achievements in the healthcare industry, including being a three-time finalist for Ernst & Young’s Entrepreneur of the Year award, receiving the Lifetime Achievement Award for Leadership and the E.G. Bailey Entrepreneurship Award, both from Ohio State University, and receiving the BBJ Innovation All-Star Award. 

He currently serves as a board member for Solect Energy Development LLC, 908 Devices, Brown University Biomedical, Massachusetts Biotech Coucil Curriculum, Boston Children’s Hospital Strategy and the Association for Lab Automation. He holds an honorary doctorate from Framingham State University and helped build curriculum for the Institute for Strategy and Competitiveness at Harvard Business School. 

Hrusovsky earned both his bachelor’s degree in mechanical engineering and his M.B.A. from Ohio State University. 

What is E Kevin Hrusovsky's net worth?

The estimated net worth of E Kevin Hrusovsky is at least $15.69 million as of May 2nd, 2022. Mr. Hrusovsky owns 911,921 shares of Quanterix stock worth more than $15,685,041 as of May 22nd. This net worth estimate does not reflect any other investments that Mr. Hrusovsky may own. Additionally, Mr. Hrusovsky receives an annual salary of $1,330,000.00 as CEO at Quanterix. Learn More about E Kevin Hrusovsky's net worth.

How old is E Kevin Hrusovsky?

Mr. Hrusovsky is currently 60 years old. There are 8 older executives and no younger executives at Quanterix. Learn More on E Kevin Hrusovsky's age.

What is E Kevin Hrusovsky's salary?

As the CEO of Quanterix Co., Mr. Hrusovsky earns $1,330,000.00 per year. Learn More on E Kevin Hrusovsky's salary.

How do I contact E Kevin Hrusovsky?

The corporate mailing address for Mr. Hrusovsky and other Quanterix executives is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. Quanterix can also be reached via phone at (617) 301-9400 and via email at [email protected] Learn More on E Kevin Hrusovsky's contact information.

Has E Kevin Hrusovsky been buying or selling shares of Quanterix?

Over the course of the past ninety days, E Kevin Hrusovsky has sold $40,369.36 in shares of Quanterix stock. As an example of a recent trade by , 0 shares of the company's stock in a transaction on Sunday, May 22nd. Learn More on E Kevin Hrusovsky's trading history.

Who are Quanterix's active insiders?

Quanterix's insider roster includes Amol Chaubal (CFO), Marijn Dekkers (Director), David Duffy (SVP), John Fry (General Counsel), E Hrusovsky (CEO), Dawn Mattoon (VP), and Mark Roskey (SVP). Learn More on Quanterix's active insiders.

Are insiders buying or selling shares of Quanterix?

During the last year, insiders at the sold shares 52 times. They sold a total of 127,776 shares worth more than $11,139,670.40. The most recent insider tranaction occured on May, 2nd when Chairman E Kevin Hrusovsky sold 649 shares worth more than $14,511.64. Insiders at Quanterix own 15.4 % of the company. Learn More about insider trades at Quanterix.

Information on this page was last updated on 5/2/2022.

E Kevin Hrusovsky Insider Trading History at Quanterix

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2022Sell649$22.36$14,511.64911,921View SEC Filing Icon  
4/1/2022Sell868$29.79$25,857.72886,976View SEC Filing Icon  
2/9/2022Sell1,364$34.97$47,699.08View SEC Filing Icon  
2/2/2022Sell589$31.46$18,529.94View SEC Filing Icon  
12/1/2021Sell3,710$40.29$149,475.90View SEC Filing Icon  
11/10/2021Sell5,000$55.18$275,900.00View SEC Filing Icon  
11/2/2021Sell3,505$52.61$184,398.05View SEC Filing Icon  
10/22/2021Sell5,000$50.70$253,500.00View SEC Filing Icon  
9/30/2021Sell5,000$49.09$245,450.00View SEC Filing Icon  
8/3/2021Sell3,648$53.79$196,225.92View SEC Filing Icon  
7/29/2021Sell5,000$54.08$270,400.00View SEC Filing Icon  
7/13/2021Sell5,000$57.45$287,250.00View SEC Filing Icon  
6/14/2021Sell5,000$66.01$330,050.00View SEC Filing Icon  
6/1/2021Sell3,854$48.32$186,225.28View SEC Filing Icon  
5/13/2021Sell5,000$46.30$231,500.00View SEC Filing Icon  
5/3/2021Sell5,789$58.21$336,977.69View SEC Filing Icon  
4/20/2021Sell5,000$58.23$291,150.00View SEC Filing Icon  
4/8/2021Sell5,000$65.54$327,700.00View SEC Filing Icon  
4/1/2021Sell3,432$62.52$214,568.64View SEC Filing Icon  
3/16/2021Sell5,000$61.32$306,600.00View SEC Filing Icon  
2/1/2021Sell8,249$66.77$550,785.73View SEC Filing Icon  
1/25/2021Sell5,000$77.81$389,050.00View SEC Filing Icon  
1/19/2021Sell5,000$74.53$372,650.00View SEC Filing Icon  
1/5/2021Sell3,510$44.13$154,896.30View SEC Filing Icon  
12/8/2020Sell2,000$46.98$93,960.00View SEC Filing Icon  
12/1/2020Sell3,236$43.75$141,575.001,023,026View SEC Filing Icon  
11/12/2020Sell2,000$49.39$98,780.00View SEC Filing Icon  
11/2/2020Sell3,264$36.97$120,670.08View SEC Filing Icon  
10/29/2020Sell2,000$38.30$76,600.00View SEC Filing Icon  
10/13/2020Sell2,000$44.49$88,980.00View SEC Filing Icon  
10/5/2020Sell2,000$33.90$67,800.00View SEC Filing Icon  
9/24/2020Sell2,000$32.26$64,520.00View SEC Filing Icon  
9/15/2020Sell3,500$33.15$116,025.00View SEC Filing Icon  
9/1/2020Sell3,390$34.91$118,344.90View SEC Filing Icon  
8/25/2020Sell3,500$35.28$123,480.00View SEC Filing Icon  
8/14/2020Sell3,500$36.72$128,520.00View SEC Filing Icon  
8/3/2020Sell3,230$32.26$104,199.80View SEC Filing Icon  
7/21/2020Sell2,636$31.87$84,009.32View SEC Filing Icon  
7/16/2020Sell4,500$27.94$125,730.00View SEC Filing Icon  
6/23/2020Sell5,000$27.07$135,350.00View SEC Filing Icon  
6/18/2020Sell5,500$26.88$147,840.00View SEC Filing Icon  
6/3/2020Sell5,000$27.49$137,450.00View SEC Filing Icon  
6/1/2020Sell3,331$27.32$91,002.92View SEC Filing Icon  
5/26/2020Sell5,000$25.64$128,200.00View SEC Filing Icon  
5/11/2020Sell5,000$27.47$137,350.00View SEC Filing Icon  
5/6/2020Sell5,000$27.09$135,450.00View SEC Filing Icon  
5/1/2020Sell3,399$25.44$86,470.56View SEC Filing Icon  
4/23/2020Sell5,000$24.92$124,600.00View SEC Filing Icon  
4/21/2020Sell5,000$23.67$118,350.00View SEC Filing Icon  
4/9/2020Sell5,000$22.07$110,350.00View SEC Filing Icon  
4/7/2020Sell5,000$20.84$104,200.00View SEC Filing Icon  
4/3/2020Sell62$20.00$1,240.00View SEC Filing Icon  
4/1/2020Sell3,233$17.44$56,383.52View SEC Filing Icon  
3/2/2020Sell8,830$22.66$200,087.801,150,565View SEC Filing Icon  
2/12/2020Sell6,500$27.17$176,605.00View SEC Filing Icon  
1/29/2020Sell6,500$26.99$175,435.00View SEC Filing Icon  
1/21/2020Sell6,500$24.07$156,455.00View SEC Filing Icon  
1/17/2020Sell6,500$24.41$158,665.00View SEC Filing Icon  
1/15/2020Sell6,500$22.17$144,105.00View SEC Filing Icon  
1/2/2020Sell3,321$23.18$76,980.78View SEC Filing Icon  
12/2/2019Sell3,357$25.06$84,126.42View SEC Filing Icon  
9/4/2019Sell3,362$25.97$87,311.14View SEC Filing Icon  
8/23/2019Sell523$26.58$13,901.34View SEC Filing Icon  
8/1/2019Sell3,167$31.62$100,140.54View SEC Filing Icon  
7/1/2019Sell3,145$34.64$108,942.80View SEC Filing Icon  
6/4/2019Sell3,073$26.00$79,898.00View SEC Filing Icon  
5/1/2019Sell2,142$22.59$48,387.78View SEC Filing Icon  
4/3/2019Sell6,817$24.06$164,017.02View SEC Filing Icon  
3/1/2019Sell1,903$25.00$47,575.00View SEC Filing Icon  
2/1/2019Sell1,952$20.90$40,796.80View SEC Filing Icon  
1/3/2019Sell1,949$17.59$34,282.91View SEC Filing Icon  
12/3/2018Sell2,940$18.46$54,272.40View SEC Filing Icon  
11/16/2018Sell4,000$16.67$66,680.00View SEC Filing Icon  
11/1/2018Sell2,829$17.97$50,837.13View SEC Filing Icon  
10/2/2018Sell2,995$20.91$62,625.45View SEC Filing Icon  
9/5/2018Sell17,909$14.53$260,217.77View SEC Filing Icon  
12/11/2017Buy34,000$15.00$510,000.00View SEC Filing Icon  
See Full Table

E Kevin Hrusovsky Buying and Selling Activity at Quanterix

This chart shows E Kevin Hrusovsky's buying and selling at Quanterix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quanterix Company Overview

Quanterix logo
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Read More

Today's Range

Now: $17.20
Low: $16.41
High: $17.80

50 Day Range

MA: $24.66
Low: $15.42
High: $30.65

2 Week Range

Now: $17.20
Low: $14.86
High: $69.22


372,771 shs

Average Volume

347,794 shs

Market Capitalization

$634.85 million

P/E Ratio


Dividend Yield



Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.